Maze Therapeutics, Inc. (MAZE)
22.52
-0.92
(-3.92%)
USD |
NASDAQ |
Sep 18, 16:00
22.61
+0.09
(+0.40%)
Pre-Market: 20:00
Maze Therapeutics EPS Diluted (Quarterly) : -0.7581 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7581 |
| March 31, 2026 | -0.4492 |
| December 31, 2025 | -0.7007 |
| September 30, 2025 | -0.6258 |
| June 30, 2025 | -0.768 |
| March 31, 2025 | -0.7486 |
| Date | Value |
|---|---|
| December 31, 2024 | -0.112 |
| September 30, 2024 | -0.0554 |
| March 31, 2024 | -0.7419 |
| December 31, 2023 | -0.6071 |
| September 30, 2023 | -0.5653 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.73M |
| Total Expenses (Quarterly) | 44.73M |
| Enterprise Value | 899.30M |
| Earnings Yield | -11.25% |
| Normalized Earnings Yield | -11.26 |